What are the causes and management of Rhabdomyolysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Rhabdomyolysis

Rhabdomyolysis results from skeletal muscle injury with four major etiologic categories: trauma/direct injury, excessive muscle activity, hereditary enzyme defects, and medical causes including drugs/toxins, infections, metabolic disorders, and temperature alterations. 1, 2

Traumatic and Physical Causes

  • Crush injuries and severe limb trauma are primary traumatic causes, with compartment syndrome both causing and complicating rhabdomyolysis 1
  • Exertional rhabdomyolysis occurs from novel overexertion or unaccustomed exercise volume/intensity, particularly during transition periods like returning after injury 1
  • Impact trauma from falls can drastically increase CK levels, though simple contusion may not carry the same acute kidney injury risk as true rhabdomyolysis 1

Drug-Induced Causes

  • Statins are the most common prescription medication cause, with an incidence of 1.6 per 100,000 patient-years, particularly simvastatin 80 mg which carries higher risk 1, 3
  • Illicit drugs (cocaine, heroin, methamphetamine, ecstasy/MDMA) and alcohol are responsible for a significant proportion of cases, with exogenous toxins accounting for 46% of all rhabdomyolysis cases 1, 3
  • Other prescription medications include antipsychotics, zidovudine, colchicine, selective serotonin reuptake inhibitors, and lithium 3
  • Dietary supplements including red yeast rice containing lovastatin, creatine monohydrate, wormwood oil, licorice, and Hydroxycut are known causative agents 1

Genetic and Metabolic Causes

  • Genetic mutations such as SLCO1B1 gene variants increase risk of statin-induced rhabdomyolysis 1
  • Hereditary muscle enzyme defects require testing for RYR1, CACNA1S (malignant hyperthermia susceptibility), CPT2, PYGM, ACADM, AMPD1, and VLCAD genes in patients with recurrent episodes 1
  • Metabolic myopathies including McArdle's disease and disorders of glycogen/lipid metabolism are predisposing factors 2, 4

Infectious and Inflammatory Causes

  • Viral myositis should be considered with appropriate viral studies when clinically indicated 1
  • Autoimmune myositis may require evaluation of markers such as ANA, ASMA, and ANCA 1
  • Infections represent a recognized category of medical causes 2

Metabolic and Endocrine Disorders

  • Electrolyte abnormalities and metabolic derangements can precipitate rhabdomyolysis 2
  • Endocrine disorders are among the medical causes requiring consideration 2

Temperature-Related Causes

  • Heat illness and exertional heat stroke can trigger rhabdomyolysis, particularly in those with malignant hyperthermia susceptibility 1, 2
  • Temperature alterations (both hyperthermia and hypothermia) are recognized triggers 2

Muscle Hypoxia and Ischemia

  • Prolonged immobilization or compression leading to muscle ischemia is a recognized cause 2
  • Muscle hypoxia from any cause can precipitate the syndrome 2

Key Risk Factors

  • Patient-specific factors including advanced age, diabetes, renal impairment, and cardiovascular disease increase susceptibility 1
  • Polypharmacy significantly increases risk, with 60% of cases involving multiple etiologic factors 3
  • History of substance abuse is a major risk factor requiring specific inquiry about recreational drug use and needle-sharing practices 1, 5

Important Clinical Considerations

  • Multiple factors are present in 60% of all cases, making it essential to identify all potential contributors rather than assuming a single cause 3
  • Recurrent rhabdomyolysis occurs in 11% of cases, with underlying myopathy or metabolic defects showing high recurrence rates 3
  • In 7% of cases, no cause is identified despite thorough evaluation 3

Management of Rhabdomyolysis

Immediate Fluid Resuscitation

Aggressive intravenous fluid resuscitation with isotonic saline targeting urine output of 300 mL/hour must be initiated immediately upon diagnosis to facilitate myoglobin clearance and prevent renal tubular obstruction. 6

  • For severe rhabdomyolysis (CK >15,000 IU/L), administer more than 6L of fluid per day 1, 6
  • For moderate cases, 3-6L per day is typically sufficient 1, 6
  • Early initiation is critical, as delayed treatment significantly increases acute kidney injury risk 1, 6
  • Monitor closely for fluid overload, particularly in patients with cardiac or renal compromise 6

Discontinue Causative Agents

  • Immediately stop all offending medications, particularly statins, antipsychotics, and any prescription drugs that may contribute 1, 6
  • Discontinue dietary supplements including red yeast rice, creatine monohydrate, wormwood oil, licorice, and Hydroxycut 1, 6
  • Avoid succinylcholine and inhaled anesthetics in anesthesia settings for patients with muscular dystrophy or at-risk populations 6

Electrolyte Monitoring and Correction

  • Check electrolyte panels every 6-12 hours in severe cases, with repeated bioassessment including plasma myoglobin, CK, and potassium 1, 6
  • Correct hyperkalemia emergently, as it can precipitate cardiac arrhythmias and arrest 1, 6
  • Monitor and correct hypocalcemia and hyperphosphatemia 6
  • Assess for metabolic acidosis via arterial blood gas, which commonly occurs in severe cases 1, 6
  • Trend CK, creatinine, and electrolytes daily until CK is declining and renal function is stable 1

Laboratory Monitoring

  • Essential initial tests include complete blood count, comprehensive metabolic panel, CK, creatinine, BUN, liver function tests, and urinalysis 1
  • Urinalysis showing brown color, cloudiness, and positive for blood without RBCs indicates myoglobinuria 1
  • Cardiac assessment including ECG and cardiac troponin should be performed in severe cases to rule out cardiac involvement 1
  • Coagulation studies should be performed to evaluate for disseminated intravascular coagulation 1

Compartment Syndrome Surveillance

  • Maintain high suspicion for compartment syndrome, monitoring for early signs including pain, tension, paresthesia, and paresis 1, 6
  • Perform early fasciotomy when compartment pressure exceeds 30 mmHg or when differential pressure (diastolic BP - compartment pressure) is <30 mmHg 1, 6
  • Late signs including pulselessness and pallor indicate irreversible damage 1, 6

Pain Management

  • Acetaminophen (500-1000 mg) is the preferred initial analgesic, with onset in 15-30 minutes and maximum daily dose of 4-6 grams 1, 6
  • Avoid all NSAIDs (ibuprofen, ketoprofen, diclofenac, naproxen, mefenamic acid) due to gastrointestinal and renal toxicity 1, 6
  • Reserve opioids for severe muscle pain unresponsive to acetaminophen, using oral morphine 20-40 mg for opioid-naive patients 1, 6
  • In patients with acute kidney injury (eGFR <30 mL/min), use fentanyl or buprenorphine as safest opioid choices 1, 6

Renal Replacement Therapy

  • Consider RRT for refractory hyperkalemia, severe metabolic acidosis, or progressive acute kidney injury 6
  • Initiate RRT if CK remains persistently elevated despite 4 days of adequate hydration 6
  • Consider discontinuation when urine output recovers adequately (>100 mL/day) 6

Genetic and Metabolic Testing

  • For recurrent episodes or family history, test for RYR1 and CACNA1S genes (malignant hyperthermia susceptibility) 1
  • For metabolic myopathies, consider CPT2, PYGM, ACADM, AMPD1, and VLCAD gene testing 1
  • If metabolic disorder suspected, test serum calcium, phosphorus, alkaline phosphatase, parathyroid hormone, and 25-hydroxy-vitamin D 1

Discharge Planning and Follow-Up

  • Schedule laboratory evaluation within 3-7 days after discharge to assess kidney recovery, including creatinine, BUN, and electrolyte panels 7
  • Continue weekly monitoring of creatinine if kidney function has not fully normalized 7
  • Arrange nephrology follow-up for patients with severe kidney injury, pre-existing chronic kidney disease, diabetes, or proteinuria 7
  • Maintain adequate oral hydration to support continued myoglobin clearance 7
  • Cease the specific physical activity that triggered the episode and return to normal activities in a graded fashion 7

Critical Pitfalls to Avoid

  • Do not delay fluid resuscitation, as this is associated with higher risk of acute kidney injury and worse outcomes 6
  • Do not use inadequate fluid volume, which may fail to prevent renal complications 6
  • Do not miss compartment syndrome, particularly in traumatic or severe exertional cases 6
  • Do not delay follow-up laboratory assessment beyond 7 days, as this can miss early signs of kidney function deterioration 7
  • Do not resume causative medications or supplements too early, as this increases risk of recurrent episodes 7

References

Guideline

Rhabdomyolysis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The other medical causes of rhabdomyolysis.

The American journal of the medical sciences, 2003

Research

Rhabdomyolysis.

American family physician, 2002

Research

Drug induced rhabdomyolysis: case report.

East African medical journal, 1997

Guideline

Management of Rhabdomyolysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rhabdomyolysis Discharge Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.